Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04260425
Other study ID # HS23437 (B2019:114)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 28, 2021
Est. completion date March 28, 2022

Study information

Verified date September 2022
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The trial will use a two period acute double-blind cross-over design to compare the effects of a serving of oatmeal containing high or low amounts of avenanthramides (AV) on post-prandial blood glucose response in healthy adults.


Description:

The clinical trial will follow a two period acute double-blind cross-over design. It will take place at Richardson Centre for Functional Food and Nutraceuticals (RCFFN) at University of Manitoba, Winnipeg, Canada. The trial will recruit healthy adult participants. Participants will consent to participate in two acute feeding sessions. Participants will be randomized to either control (low avenanthramides) then treatment (high avenanthramides) or treatment then control. Participants will arrive at the study center fasted between 8 and 10:30 am on the session days. They will be provided either the study treatment or control product based on randomization sequence for their first study visit. Baseline blood glucose (0 min) will be measured in duplicate via finger stick blood sample right before their first bite of the treatment product, and at 15, 30, 45, 60, 90 and 120 mins after baseline. The timer will be started when they take their first bite. During the second visit participant will consume the other treatment based on the randomization (the oatmeal that they didn't receive in their first visit and follow exactly the same procedure as the first visit). There will be a minimum of 5 days between sessions. Female participants will be scheduled during the luteal phase of their menstruation cycle. There will be a maximum of 8 weeks between the two sessions, therefore, participants will finish the both sessions within an 8 week period.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date March 28, 2022
Est. primary completion date March 28, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Participant is willing and able to give informed consent for participation in the trial - Male or female between 18-50 years old - BMI range in between 18.9-29.9 kg/m^2 - Fasting glucose <5.6 mmol/L - Usually eat breakfast - In the Investigator's opinion is able and willing to comply with all trial requirements Exclusion Criteria: - Fasting glucose = 5.6 mmol/L or <3.5 mmol/L - Female participant who is pregnant, lactating or planning pregnancy during the course of the trial - Participants who indicate that they could not finish consuming the study treatments within 10 minutes - Use of medication or supplements that may influence carbohydrate metabolism, including, but not limited to adrenergic blockers, diuretics, thiazolidinediones, metformin and systemic corticosteroids within 4 weeks of screening visit - History of disordered eating, AIDS, hepatitis, a history of clinically important endocrine (including Type I and Type II diabetes mellitus), cardiovascular (including but not limit to atherosclerotic disease, history of myocardial infarction, peripheral arterial disease, stroke), pulmonary, biliary or GI disorders - Intolerance or allergic reaction to oats - Existing restrictive dietary habits (such a vegan, low carbohydrate or keto) - Uncontrolled hypertension - History of cancer within the last two years (except for non-melanoma skin cancer) - Recent history of (within 12 month of screening) or current strong potential for alcohol or substance abuse. Alcohol abuse is defined as >14 drinks per week, (1 drink = 12oz of beer, 5oz of wine or 1.5oz distilled spirits) - Body weight change over 3.5kg within the past 3 months - Participants who have participated in another research trial involving an investigational product in the past 12 weeks - Had significant physical trauma or major surgery in the past 3 month or had trauma or major surgery in the past 3 month

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Serving of oatmeal made from low avenanthramides oats and water
One serving size (40 grams dry weight) of low avenanthramides oats flakes will be used to make oatmeal. One cup of water and a dash of salt (0.72 g) will be added into the treatment and microwaved on high for 3 minutes. It will be stirred before serving. Ingredients and cooking time will be consistently maintained throughout.
Serving of oatmeal made from high avenanthramides oats and water
One serving size (40 grams dry weight) of high avenanthramides oats flakes will be used to make oatmeal. One cup of water and a dash of salt (0.72 g) will be added into the treatment and microwaved on high for 3 minutes. It will be stirred before serving. Ingredients and cooking time will be consistently maintained throughout.

Locations

Country Name City State
Canada Richardson Center for Food Technology and Research Winnipeg Manitoba

Sponsors (2)

Lead Sponsor Collaborator
University of Manitoba Agriculture and Agri-Food Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary post-prandial glucose response 2 hour area under the curve of post-prandial glucose response to the interventions in mmol/L*min^2 Area under the curve from 0,15, 30, 45, 60, 90 and 120 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04578067 - Empowering Immigrant Women for Active and Healthy Lifestyle N/A
Completed NCT04256746 - Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose N/A
Completed NCT02536066 - Daily Physical Activity After Meals -Long Term Effects on Blood Glucose N/A
Completed NCT03254082 - Glycemic Response of Sorghum N/A
Completed NCT00444171 - Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients N/A
Completed NCT00302302 - The Effects of L-arabinose on Intestinal Sucrase Activity in Man Phase 1
Completed NCT04378374 - The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake N/A
Completed NCT04451655 - Glycemic Stability During the Intraoperative Period Among Patients With DM Undergoing CABG Surgery N/A
Recruiting NCT04989712 - MOReS Freestyle Libre Validation Study N/A
Completed NCT05352724 - Clinical Trial to Evaluate the Efficacy of a Sport Drink After High-intensity Aerobic Exercise N/A
Completed NCT04258501 - Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response N/A
Completed NCT02968498 - Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers N/A
Completed NCT02484313 - The Effect of Snacks on Glycaemic Regulation in Children N/A
Withdrawn NCT01246492 - The Effect of Artificial Sweeteners on Blood Glucose Response N/A
Completed NCT01241253 - Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus Phase 2
Completed NCT03914430 - Breakfast Cereals Consumed in Dairy and Non-dairy Medium: the Effects on Blood Glucose, Satiety and Food Intake N/A
Recruiting NCT05255783 - The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients N/A
Completed NCT05573607 - Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life N/A
Recruiting NCT05585801 - Continuous Glucose Monitoring in Intensive Care Unit N/A
Active, not recruiting NCT03978104 - Impact of Okara and Bio-okara Food Product on Gut and Glycaemic Health in Middle-aged and Older Adults in Singapore N/A